Herbs (Global Traditional) · African
Euphorbia hirta
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Euphorbia hirta contains flavonoids and triterpenoids that demonstrate anti-inflammatory activity through inhibition of nitric oxide production in immune cells. The plant's anxiolytic effects appear to work via GABA_A receptor modulation in the central nervous system.
Euphorbia hirta is a pantropical annual herbaceous plant from the Euphorbiaceae family, native to Africa, Asia, Australia, and the Americas, commonly known as asthma weed or snakeweed. The whole plant, particularly aerial parts including dried leaves and stems, is extracted using solvents like ethanol (65-70%), methanol, or n-hexane to produce medicinal preparations rich in flavonoids, tannins, and terpenoids.
Clinical evidence for Euphorbia hirta is extremely limited, with only one systematic review (PMID: 29849664) identifying a single human trial among eight studies on antidengue activity, though trial details were not specified. The majority of research consists of animal studies (anxiolytic effects in rats at 200 mg/kg) and in vitro investigations demonstrating anti-inflammatory and cytotoxic properties in various cell lines.
Animal studies used 200 mg/kg oral daily for anxiolytic effects. Toxicity studies in rats showed safety up to 5000 mg/kg single dose and 1000 mg/kg daily for 90 days. No standardized human dosages have been established through clinical trials. Consult a healthcare provider before starting any new supplement.
Euphorbia hirta is not consumed as a conventional food, so standard macronutrient profiling (carbohydrates, fats, protein per 100 g edible portion) is limited. It is primarily valued for its bioactive phytochemical content rather than caloric or macronutrient contribution. Key compounds identified include: **Flavonoids:** Quercetin (approximately 0.8–1.5 mg/g dry weight), quercitrin, myricitrin, and rutin, which contribute to its antioxidant and anti-inflammatory activity. **Polyphenols:** Total phenolic content reported in the range of 45–85 mg gallic acid equivalents (GAE)/g dry extract, depending on solvent and plant part. **Tannins:** Ellagic acid and gallic acid derivatives present at approximately 10–25 mg/g dry extract; these contribute astringent and antimicrobial properties but may reduce bioavailability of dietary iron and proteins if co-consumed. **Terpenoids:** Euphol, taraxerol, and β-amyrin identified in stem latex and whole-plant extracts; concentrations vary but are typically in the low mg/g range in crude extracts. **Alkaloids:** Trace amounts detected in whole-plant methanolic extracts. **Sterols:** β-sitosterol and campesterol present in small quantities (approximately 0.2–0.5 mg/g dry weight). **Minerals (from whole dried herb):** Potassium (~12–18 mg/g), calcium (~8–15 mg/g), magnesium (~3–6 mg/g), iron (~0.3–0.8 mg/g), and zinc (~0.03–0.08 mg/g) have been reported in elemental analyses of dried aerial parts; however, bioavailability is likely reduced by tannin content. **Vitamins:** Ascorbic acid (vitamin C) has been detected in fresh leaf tissue at approximately 30–60 mg/100 g fresh weight, though this degrades significantly upon drying or boiling. **Fiber:** Crude fiber in dried whole herb is estimated at 15–22% by weight, typical of leafy herbaceous plants. **Fatty acids:** Linoleic acid and oleic acid are the predominant fatty acids in seed oil fractions, though total lipid content of the whole plant is low (~2–4% dry weight). **Bioavailability notes:** Most pharmacological studies use concentrated methanolic or ethanolic extracts; bioavailability of key flavonoids like quercetin from crude decoctions (traditional preparation) is expected to be low (typically <5–10% oral absorption in humans). The presence of tannins may further chelate minerals and reduce polyphenol absorption. No human pharmacokinetic studies specific to Euphorbia hirta preparations are currently available.
Euphorbia hirta's flavonoid compounds inhibit nitric oxide synthase in activated macrophages, reducing inflammatory nitric oxide production at concentrations of 200 µg/mL. The plant's anxiolytic activity involves modulation of GABA_A receptors in the central nervous system, enhancing inhibitory neurotransmission. Triterpenoid compounds may contribute to both anti-inflammatory and neurological effects through multiple signaling pathways.
Anti-inflammatory effects have been demonstrated only in vitro using RAW264.7 macrophage cells, showing reduced nitric oxide production with 200 µg/mL extract treatment. Anxiolytic properties were observed in animal studies using rat models at 200 mg/kg oral doses administered for 7 days. No human clinical trials have been conducted to validate these preliminary findings. The evidence remains limited to laboratory and animal studies, requiring human research for clinical relevance.
Safety data for Euphorbia hirta is extremely limited with no established human dosing guidelines or toxicity profiles. As a member of the Euphorbia family, it may contain latex compounds that could cause skin irritation or allergic reactions in sensitive individuals. Potential interactions with GABA-ergic medications like benzodiazepines or anticonvulsants are theoretically possible given its GABA_A receptor activity. Pregnant and breastfeeding women should avoid use due to lack of safety data.
